P53- and mevalonate pathway–driven malignancies require Arf6 for metastasis and drug resistance
Ari Hashimoto(Hokkaido University), Hisataka Sabe(Hokkaido University)
Cited by 58
Related Papers
Rab5c promotes AMAP1–PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion
|The Journal of Cell Biology|2012|110
Succinyl-CoA-based energy metabolism dysfunction in chronic heart failure
|Proceedings of the National Academy of Sciences|2022|56
ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance
|Oncogenesis|2016|45